Analysts at StockNews.com initiated coverage on shares of Pro-Dex (NASDAQ:PDEX – Get Rating) in a report issued on Wednesday. The brokerage set a "hold" rating on the medical instruments supplier's stock.
Pro-Dex Trading Up 1.6 %
Shares of NASDAQ:PDEX opened at $17.79 on Wednesday. The company has a quick ratio of 1.39, a current ratio of 2.73 and a debt-to-equity ratio of 0.41. Pro-Dex has a 12-month low of $12.40 and a 12-month high of $26.50. The firm has a fifty day moving average of $18.19 and a two-hundred day moving average of $17.19. The firm has a market capitalization of $63.69 million, a P/E ratio of 17.11 and a beta of 0.91.
Get Pro-Dex alerts:Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently made changes to their positions in PDEX. Tower Research Capital LLC TRC boosted its position in Pro-Dex by 345.6% in the third quarter. Tower Research Capital LLC TRC now owns 2,687 shares of the medical instruments supplier's stock valued at $48,000 after buying an additional 2,084 shares in the last quarter. Renaissance Technologies LLC bought a new stake in shares of Pro-Dex during the second quarter worth $168,000. State Street Corp increased its position in shares of Pro-Dex by 5.8% during the first quarter. State Street Corp now owns 11,923 shares of the medical instruments supplier's stock worth $197,000 after acquiring an additional 650 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in Pro-Dex by 59.2% during the first quarter. JPMorgan Chase & Co. now owns 20,863 shares of the medical instruments supplier's stock worth $345,000 after purchasing an additional 7,762 shares during the last quarter. Finally, LSV Asset Management boosted its holdings in Pro-Dex by 13.9% during the first quarter. LSV Asset Management now owns 35,581 shares of the medical instruments supplier's stock worth $588,000 after purchasing an additional 4,346 shares during the last quarter. Institutional investors own 13.69% of the company's stock.
About Pro-Dex
(Get Rating)Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.
See Also
- Get a free copy of the StockNews.com research report on Pro-Dex (PDEX)
- Can Pfizer, Johnson & Johnson Continue Outperforming the Index?
- This Is Why Daktronics Fell 40% In One Day
- Is It Time To Throw In The Towel On Gamestop?
- Why You Should Avoid Carvana Even if it Avoids Bankruptcy
- Are Investors Hearing The End Of Spotify's Downtrend?
Receive News & Ratings for Pro-Dex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro-Dex and related companies with MarketBeat.com's FREE daily email newsletter.